FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40213511000001102: Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Nov 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2079451000001114 Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2079461000001112 Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets Is a Tucatinib 50mg tablets 88 tablet true Inferred relationship Existential restriction modifier
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets Has AMP Tukysa 50mg tablets (Seagen U.K. Ltd) true Inferred relationship Existential restriction modifier
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets Has specific active ingredient Tucatinib true Inferred relationship Existential restriction modifier
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tukysa 50mg tablets (Seagen U.K. Ltd) 88 tablet 11 x 8 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start